메뉴 건너뛰기




Volumn 19, Issue 5, 2015, Pages 1151-1161

High-mobility group box-1 induces vascular remodelling processes via c-Jun activation

Author keywords

Alarmins; HMGB1; Inflammation; Proliferation; Pulmonary hypertension

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; AGER PROTEIN, HUMAN; HIGH MOBILITY GROUP B1 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TLR4 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 4;

EID: 84928423492     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12519     Document Type: Article
Times cited : (56)

References (43)
  • 1
    • 84864748513 scopus 로고    scopus 로고
    • Alarmins: awaiting a clinical response
    • Chan JK, Roth J, Oppenheim JJ, et al. Alarmins: awaiting a clinical response. J Clin Invest. 2012; 122: 2711-9.
    • (2012) J Clin Invest , vol.122 , pp. 2711-2719
    • Chan, J.K.1    Roth, J.2    Oppenheim, J.J.3
  • 2
    • 0036957367 scopus 로고    scopus 로고
    • HMGB1 as a cytokine and therapeutic target
    • Yang H, Wang H, Czura CJ, et al. HMGB1 as a cytokine and therapeutic target. J Endotoxin Res. 2002; 8: 469-72.
    • (2002) J Endotoxin Res , vol.8 , pp. 469-472
    • Yang, H.1    Wang, H.2    Czura, C.J.3
  • 3
    • 0034664791 scopus 로고    scopus 로고
    • HMG-1 as a mediator of acute lung inflammation
    • Abraham E, Arcaroli J, Carmody A, et al. HMG-1 as a mediator of acute lung inflammation. J Immunol. 2000; 165: 2950-4.
    • (2000) J Immunol , vol.165 , pp. 2950-2954
    • Abraham, E.1    Arcaroli, J.2    Carmody, A.3
  • 4
    • 79960726338 scopus 로고    scopus 로고
    • High mobility group protein B1 (HMGB1) in Asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls
    • Hou C, Zhao H, Liu L, et al. High mobility group protein B1 (HMGB1) in Asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls. Mol Med. 2011; 17: 807-15.
    • (2011) Mol Med , vol.17 , pp. 807-815
    • Hou, C.1    Zhao, H.2    Liu, L.3
  • 5
    • 61849089739 scopus 로고    scopus 로고
    • Clinical significance of serum HMGB-1 and sRAGE levels in systemic sclerosis: association with disease severity
    • Yoshizaki A, Komura K, Iwata Y, et al. Clinical significance of serum HMGB-1 and sRAGE levels in systemic sclerosis: association with disease severity. J Clin Immunol. 2009; 29: 180-9.
    • (2009) J Clin Immunol , vol.29 , pp. 180-189
    • Yoshizaki, A.1    Komura, K.2    Iwata, Y.3
  • 6
    • 53349099086 scopus 로고    scopus 로고
    • The role of high mobility group box1 in pulmonary fibrosis
    • Hamada N, Maeyama T, Kawaguchi T, et al. The role of high mobility group box1 in pulmonary fibrosis. Am J Respir Cell Mol Biol. 2008; 39: 440-7.
    • (2008) Am J Respir Cell Mol Biol , vol.39 , pp. 440-447
    • Hamada, N.1    Maeyama, T.2    Kawaguchi, T.3
  • 7
    • 84867845975 scopus 로고    scopus 로고
    • HMGB1 and RAGE levels in induced sputum correlate with asthma severity and neutrophil percentage
    • Zhou Y, Jiang YQ, Wang WX, et al. HMGB1 and RAGE levels in induced sputum correlate with asthma severity and neutrophil percentage. Hum Immunol. 2012; 73: 1171-4.
    • (2012) Hum Immunol , vol.73 , pp. 1171-1174
    • Zhou, Y.1    Jiang, Y.Q.2    Wang, W.X.3
  • 8
    • 77952307233 scopus 로고    scopus 로고
    • Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease
    • Ferhani N, Letuve S, Kozhich A, et al. Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010; 181: 917-27.
    • (2010) Am J Respir Crit Care Med , vol.181 , pp. 917-927
    • Ferhani, N.1    Letuve, S.2    Kozhich, A.3
  • 9
    • 84870523226 scopus 로고    scopus 로고
    • Molecular pathogenesis of pulmonary arterial hypertension
    • Rabinovitch M. Molecular pathogenesis of pulmonary arterial hypertension. J Clin Invest. 2012; 122: 4306-13.
    • (2012) J Clin Invest , vol.122 , pp. 4306-4313
    • Rabinovitch, M.1
  • 10
    • 31044444627 scopus 로고    scopus 로고
    • Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease
    • Trad S, Amoura Z, Beigelman C, et al. Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease. Arthritis Rheum. 2006; 54: 184-91.
    • (2006) Arthritis Rheum , vol.54 , pp. 184-191
    • Trad, S.1    Amoura, Z.2    Beigelman, C.3
  • 11
    • 34249784805 scopus 로고    scopus 로고
    • Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment
    • Proudman SM, Stevens WM, Sahhar J, et al. Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment. Intern Med J. 2007; 37: 485-94.
    • (2007) Intern Med J , vol.37 , pp. 485-494
    • Proudman, S.M.1    Stevens, W.M.2    Sahhar, J.3
  • 12
    • 0028298825 scopus 로고
    • Pulmonary hypertension in patients with human immunodeficiency virus infection. Comparison with primary pulmonary hypertension
    • Petitpretz P, Brenot F, Azarian R, et al. Pulmonary hypertension in patients with human immunodeficiency virus infection. Comparison with primary pulmonary hypertension. Circulation. 1994; 89: 2722-7.
    • (1994) Circulation , vol.89 , pp. 2722-2727
    • Petitpretz, P.1    Brenot, F.2    Azarian, R.3
  • 14
    • 33947370516 scopus 로고    scopus 로고
    • Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis
    • Hamada K, Nagai S, Tanaka S, et al. Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. Chest. 2007; 131: 650-6.
    • (2007) Chest , vol.131 , pp. 650-656
    • Hamada, K.1    Nagai, S.2    Tanaka, S.3
  • 15
    • 33645118315 scopus 로고    scopus 로고
    • Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis
    • Lettieri CJ, Nathan SD, Barnett SD, et al. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest. 2006; 129: 746-52.
    • (2006) Chest , vol.129 , pp. 746-752
    • Lettieri, C.J.1    Nathan, S.D.2    Barnett, S.D.3
  • 16
    • 3142517968 scopus 로고    scopus 로고
    • Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis
    • Gan WQ, Man SF, Senthilselvan A, et al. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004; 59: 574-80.
    • (2004) Thorax , vol.59 , pp. 574-580
    • Gan, W.Q.1    Man, S.F.2    Senthilselvan, A.3
  • 17
    • 84864522564 scopus 로고    scopus 로고
    • Modern age pathology of pulmonary arterial hypertension
    • Stacher E, Graham BB, Hunt JM, et al. Modern age pathology of pulmonary arterial hypertension. Am J Respir Crit Care Med. 2012; 186: 261-72.
    • (2012) Am J Respir Crit Care Med , vol.186 , pp. 261-272
    • Stacher, E.1    Graham, B.B.2    Hunt, J.M.3
  • 18
    • 84855467311 scopus 로고    scopus 로고
    • Inflammation in pulmonary arterial hypertension
    • Price LC, Wort SJ, Perros F, et al. Inflammation in pulmonary arterial hypertension. Chest. 2012; 141: 210-21.
    • (2012) Chest , vol.141 , pp. 210-221
    • Price, L.C.1    Wort, S.J.2    Perros, F.3
  • 19
    • 84868283518 scopus 로고    scopus 로고
    • Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension
    • Savai R, Pullamsetti SS, Kolbe J, et al. Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med. 2012; 186: 897-908.
    • (2012) Am J Respir Crit Care Med , vol.186 , pp. 897-908
    • Savai, R.1    Pullamsetti, S.S.2    Kolbe, J.3
  • 20
    • 0028282859 scopus 로고
    • Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension
    • Tuder RM, Groves B, Badesch DB, et al. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol. 1994; 144: 275-85.
    • (1994) Am J Pathol , vol.144 , pp. 275-285
    • Tuder, R.M.1    Groves, B.2    Badesch, D.B.3
  • 21
    • 84902950876 scopus 로고    scopus 로고
    • Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension
    • Rabinovitch M, Guignabert C, Humbert M, et al. Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. Circ Res. 2014; 115: 165-75.
    • (2014) Circ Res , vol.115 , pp. 165-175
    • Rabinovitch, M.1    Guignabert, C.2    Humbert, M.3
  • 22
    • 84871709863 scopus 로고    scopus 로고
    • [Levels of HMGB1 in induced sputum from patients with asthma and chronic obstructive pulmonary disease]
    • Cheng Z, Kang Y, Wu QG, et al. [Levels of HMGB1 in induced sputum from patients with asthma and chronic obstructive pulmonary disease]. Zhonghua Yi Xue Za Zhi. 2011; 91: 2981-4.
    • (2011) Zhonghua Yi Xue Za Zhi , vol.91 , pp. 2981-2984
    • Cheng, Z.1    Kang, Y.2    Wu, Q.G.3
  • 23
    • 84873509875 scopus 로고    scopus 로고
    • High mobility group box 1 contributes to the pathogenesis of experimental pulmonary hypertension via activation of Toll-like receptor 4
    • Bauer EM, Shapiro R, Zheng H, et al. High mobility group box 1 contributes to the pathogenesis of experimental pulmonary hypertension via activation of Toll-like receptor 4. Mol Med. 2012; 18: 1509-18.
    • (2012) Mol Med , vol.18 , pp. 1509-1518
    • Bauer, E.M.1    Shapiro, R.2    Zheng, H.3
  • 24
    • 0037769813 scopus 로고    scopus 로고
    • Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells
    • Fiuza C, Bustin M, Talwar S, et al. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood. 2003; 101: 2652-60.
    • (2003) Blood , vol.101 , pp. 2652-2660
    • Fiuza, C.1    Bustin, M.2    Talwar, S.3
  • 25
    • 0029062419 scopus 로고
    • Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension
    • Humbert M, Monti G, Brenot F, et al. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am J Respir Crit Care Med. 1995; 151: 1628-31.
    • (1995) Am J Respir Crit Care Med , vol.151 , pp. 1628-1631
    • Humbert, M.1    Monti, G.2    Brenot, F.3
  • 26
    • 77956390581 scopus 로고    scopus 로고
    • Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension
    • Soon E, Holmes AM, Treacy CM, et al. Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. Circulation. 2010; 122: 920-7.
    • (2010) Circulation , vol.122 , pp. 920-927
    • Soon, E.1    Holmes, A.M.2    Treacy, C.M.3
  • 27
    • 0037092565 scopus 로고    scopus 로고
    • CX(3)C chemokine fractalkine in pulmonary arterial hypertension
    • Balabanian K, Foussat A, Dorfmuller P, et al. CX(3)C chemokine fractalkine in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2002; 165: 1419-25.
    • (2002) Am J Respir Crit Care Med , vol.165 , pp. 1419-1425
    • Balabanian, K.1    Foussat, A.2    Dorfmuller, P.3
  • 29
    • 33644824392 scopus 로고    scopus 로고
    • Increased plasma monocyte chemoattractant protein-1 level in idiopathic pulmonary arterial hypertension
    • Itoh T, Nagaya N, Ishibashi-Ueda H, et al. Increased plasma monocyte chemoattractant protein-1 level in idiopathic pulmonary arterial hypertension. Respirology. 2006; 11: 158-63.
    • (2006) Respirology , vol.11 , pp. 158-163
    • Itoh, T.1    Nagaya, N.2    Ishibashi-Ueda, H.3
  • 30
    • 36248952716 scopus 로고    scopus 로고
    • Role of endothelium-derived CC chemokine ligand 2 in idiopathic pulmonary arterial hypertension
    • Sanchez O, Marcos E, Perros F, et al. Role of endothelium-derived CC chemokine ligand 2 in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med. 2007; 176: 1041-7.
    • (2007) Am J Respir Crit Care Med , vol.176 , pp. 1041-1047
    • Sanchez, O.1    Marcos, E.2    Perros, F.3
  • 31
    • 84903846674 scopus 로고    scopus 로고
    • Distinct differences in gene expression patterns in pulmonary arteries of patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis with pulmonary hypertension
    • Hoffmann J, Wilhelm J, Marsh LM, et al. Distinct differences in gene expression patterns in pulmonary arteries of patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis with pulmonary hypertension. Am J Respir Crit Care Med. 2014; 190: 98-111.
    • (2014) Am J Respir Crit Care Med , vol.190 , pp. 98-111
    • Hoffmann, J.1    Wilhelm, J.2    Marsh, L.M.3
  • 32
    • 0023873580 scopus 로고
    • Pulmonary vascular structure and function in chronic obstructive pulmonary disease
    • Magee F, Wright JL, Wiggs BR, et al. Pulmonary vascular structure and function in chronic obstructive pulmonary disease. Thorax. 1988; 43: 183-9.
    • (1988) Thorax , vol.43 , pp. 183-189
    • Magee, F.1    Wright, J.L.2    Wiggs, B.R.3
  • 33
    • 80052178805 scopus 로고    scopus 로고
    • Pulmonary artery smooth muscle cell senescence is a pathogenic mechanism for pulmonary hypertension in chronic lung disease
    • Noureddine H, Gary-Bobo G, Alifano M, et al. Pulmonary artery smooth muscle cell senescence is a pathogenic mechanism for pulmonary hypertension in chronic lung disease. Circ Res. 2011; 109: 543-53.
    • (2011) Circ Res , vol.109 , pp. 543-553
    • Noureddine, H.1    Gary-Bobo, G.2    Alifano, M.3
  • 34
    • 0036212004 scopus 로고    scopus 로고
    • Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD
    • Santos S, Peinado VI, Ramirez J, et al. Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD. Eur Respir J. 2002; 19: 632-8.
    • (2002) Eur Respir J , vol.19 , pp. 632-638
    • Santos, S.1    Peinado, V.I.2    Ramirez, J.3
  • 35
    • 29644441337 scopus 로고    scopus 로고
    • Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine
    • Mitola S, Belleri M, Urbinati C, et al. Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. J Immunol. 2006; 176: 12-5.
    • (2006) J Immunol , vol.176 , pp. 12-15
    • Mitola, S.1    Belleri, M.2    Urbinati, C.3
  • 36
    • 33845649733 scopus 로고    scopus 로고
    • Smooth muscle cells in human atherosclerotic plaques secrete and proliferate in response to high mobility group box 1 protein
    • Porto A, Palumbo R, Pieroni M, et al. Smooth muscle cells in human atherosclerotic plaques secrete and proliferate in response to high mobility group box 1 protein. FASEB J. 2006; 20: 2565-6.
    • (2006) FASEB J , vol.20 , pp. 2565-2566
    • Porto, A.1    Palumbo, R.2    Pieroni, M.3
  • 37
    • 84860794215 scopus 로고    scopus 로고
    • Astrocytic high-mobility group box 1 promotes endothelial progenitor cell-mediated neurovascular remodeling during stroke recovery
    • Hayakawa K, Pham LD, Katusic ZS, et al. Astrocytic high-mobility group box 1 promotes endothelial progenitor cell-mediated neurovascular remodeling during stroke recovery. Proc Natl Acad Sci U S A. 2012; 109: 7505-10.
    • (2012) Proc Natl Acad Sci U S A , vol.109 , pp. 7505-7510
    • Hayakawa, K.1    Pham, L.D.2    Katusic, Z.S.3
  • 38
    • 84872298261 scopus 로고    scopus 로고
    • High mobility group Box 1 inhibits human pulmonary artery endothelial cell migration via a Toll-like receptor 4- and interferon response factor 3-dependent mechanism(s)
    • Bauer EM, Shapiro R, Billiar TR, et al. High mobility group Box 1 inhibits human pulmonary artery endothelial cell migration via a Toll-like receptor 4- and interferon response factor 3-dependent mechanism(s). J Biol Chem. 2013; 288: 1365-73.
    • (2013) J Biol Chem , vol.288 , pp. 1365-1373
    • Bauer, E.M.1    Shapiro, R.2    Billiar, T.R.3
  • 39
    • 0035911959 scopus 로고    scopus 로고
    • The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells
    • Degryse B, Bonaldi T, Scaffidi P, et al. The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J Cell Biol. 2001; 152: 1197-206.
    • (2001) J Cell Biol , vol.152 , pp. 1197-1206
    • Degryse, B.1    Bonaldi, T.2    Scaffidi, P.3
  • 40
    • 84877806447 scopus 로고    scopus 로고
    • High mobility group box-1 promotes the proliferation and migration of hepatic stellate cells via TLR4-dependent signal pathways of PI3K/Akt and JNK
    • Wang FP, Li L, Li J, et al. High mobility group box-1 promotes the proliferation and migration of hepatic stellate cells via TLR4-dependent signal pathways of PI3K/Akt and JNK. PLoS ONE. 2013; 8: e64373.
    • (2013) PLoS ONE , vol.8 , pp. e64373
    • Wang, F.P.1    Li, L.2    Li, J.3
  • 41
    • 75749109330 scopus 로고    scopus 로고
    • Bone development and inflammatory disease is regulated by AP-1 (Fos/Jun)
    • Wagner EF. Bone development and inflammatory disease is regulated by AP-1 (Fos/Jun). Ann Rheum Dis. 2010; 69(Suppl. 1): i86-8.
    • (2010) Ann Rheum Dis , vol.69 , pp. i86-i88
    • Wagner, E.F.1
  • 42
    • 84898596426 scopus 로고    scopus 로고
    • Meprin beta, a novel mediator of vascular remodelling underlying pulmonary hypertension
    • Biasin V, Marsh LM, Egemnazarov B, et al. Meprin beta, a novel mediator of vascular remodelling underlying pulmonary hypertension. J Pathol. 2014; 233: 7-17.
    • (2014) J Pathol , vol.233 , pp. 7-17
    • Biasin, V.1    Marsh, L.M.2    Egemnazarov, B.3
  • 43
    • 84904480132 scopus 로고    scopus 로고
    • HMGB1 promotes the development of pulmonary arterial hypertension in rats
    • Sadamura-Takenaka Y, Ito T, Noma S, et al. HMGB1 promotes the development of pulmonary arterial hypertension in rats. PLoS ONE. 2014; 9: e102482.
    • (2014) PLoS ONE , vol.9 , pp. e102482
    • Sadamura-Takenaka, Y.1    Ito, T.2    Noma, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.